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Introduction: Age-related changes in muscle mass and muscle tissue composition
contribute to diminished strength in older adults. The objectives of this study are
to examine if an assessment method using mobile diagnostic ultrasound augments
well-known determinants of lean body mass (LBM) to aid sarcopenia staging, and if a
sonographic measure of muscle quality is associated with muscle performance.
Methods: Twenty community-dwelling female subjects participated in the study (age =
43.4± 20.9 years; BMI: 23.8, interquartile range: 8.5). Dual energy X-ray absorptiometry
(DXA) and diagnostic ultrasoundmorphometry were used to estimate LBM.Muscle tissue
quality was estimated via the echogenicity using grayscale histogram analysis. Peak force
was measured with grip dynamometry and scaled for body size. Bivariate and multiple
regression analyses were used to determine the association of the predictor variables with
appendicular lean mass (aLM/ht2), and examine the relationship between scaled peak
force values and muscle echogenicity. The sarcopenia LBM cut point value of 6.75 kg/m2
determined participant assignment into the Normal LBM and Low LBM subgroups.
Results: The selected LBM predictor variables were body mass index (BMI), ultrasound
morphometry, and age. Although BMI exhibited a significant positive relationship with
aLM/ht2 (adj. R2 = 0.61, p < 0.001), the strength of association improved with the
addition of ultrasound morphometry and age as predictor variables (adj. R2 = 0.85, p <
0.001). Scaled peak force was associated with age and echogenicity (adj. R2 = 0.53,
p < 0.001), but not LBM. The Low LBM subgroup of women (n = 10) had higher scaled
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peak force, lower BMI, and lower echogenicity values in comparison to the Normal LBM
subgroup (n = 10; p < 0.05).
Conclusions: Diagnostic ultrasoundmorphometry values are associated with LBM, and
improve the BMI predictive model for aLM/ht2 in women. In addition, ultrasound proxy
measures of muscle quality are more strongly associated with strength than muscle mass
within the study sample.
Keywords: sarcopenia, diagnostic ultrasound, geriatric assessment, body composition, dual-energy X-ray
absorptiometry, muscle performance, muscle strength, myosteatosis
INTRODUCTION
Age-related declines in strength typically begin during the
4th decade of life, and range from 0.6 to 1.3% per year in
people over 65 years of age (Hughes et al., 2001; Kamel,
2003; Frontera et al., 2008). Sarcopenia, an age-related loss
of muscle mass that contributes to diminished muscle power
and independent mobility, has been noted as a significant
cause of morbidity in older adults (Janssen et al., 2004;
Mitchell et al., 2012). The pathogenesis of sarcopenia is
multifactorial and likely involves inflammatory, endocrine,
neurological, and behavioral contributors. Importantly, the
strength changes in older adults are often accompanied
by myosteatosis, an increase in intramuscular adipose and
connective tissue, along with the concomitant decrease in
skeletal muscle cross-sectional area (Vandervoort, 2002; Kamel,
2003). These changes in muscle quality (e.g., muscle tissue
composition, metabolic efficiency, or altered mechanics)
may negatively impact functional performance in both
women and men. Moreover, increased myosteatosis has
been shown to be associated with decreased bone mineral
density and lean body mass (LBM) in older women (Song et al.,
2004).
Diminished LBM, muscle tissue composition, and muscle
performance, are significant contributors to geriatric syndromes
such as sarcopenia and frailty, and merit focused attention
regarding standardized assessment and rehabilitation
intervention strategies. Despite the substantial clinical and
financial burden attributed to sarcopenia, it remains an under-
diagnosed condition that is rarely subject to a systematic
screening process for older adults (Fielding et al., 2011). The
most commonly used LBM criterion for sarcopenia staging is
appendicular lean mass (aLM, also expressed as aLM/ht2), as
measured by dual energy X-ray absorptiometry (DXA) (Cruz-
Jentoft and Morley, 2012; Malmstrom et al., 2013). However, due
to space requirements for DXA, initial equipment costs, body
size constraints, and general barriers related to specialized LBM
assessment software and examiner training, DXA assessment of
aLM is not an ideal measure for large scale sarcopenia clinical
trials, bedside assessment, or community health screening
efforts. Individual attributes such as age and sex are meaningful
determinants of LBM, and alternative anthropometric methods
have been used to estimate LBM (Harris-Love et al., 2014a).
In addition, BMI has been shown to explain a significant
proportion of the variance in LBM values (Iannuzzi-Sucich
et al., 2002). However, these alternative estimates of LBM
have limited utility as proxy measures, and the standard DXA
examination does not provide information concerning muscle
quality.
The use of diagnostic ultrasound for body composition
assessment has been explored in concurrent validity studies
involving DXA, hydrostatic weighing, and computed
tomography (CT) imaging (Pineau et al., 2007; Utter and Hager,
2008). Also, sonographic characteristics of skeletal muscle have
been associated with density values from magnetic resonance
imaging (MRI) (Abe et al., 1994) and hydrodensitometry
(Sanada et al., 2006) in Japanese adults. Unlike DXA, but similar
to magnetic resonance and CT imaging, diagnostic ultrasound
may be used to assess muscle quality via tissue characteristics.
Muscle quality may be assessed via diagnostic ultrasound due to
the hyperechoic nature of the non-contractile tissue associated
with myosteatosis (Sipilä and Suominen, 1993). The use of
diagnostic ultrasound for muscle tissue characterization has
also been successful in the detection of various disorders such
as Duchenne muscular dystrophy (Cady and Gardener, 1983;
Berger et al., 1987; Schapira et al., 1987; Hughes et al., 2007).
Moreover, the analysis of muscle tissue acquired via biopsy
suggests that echogenicity is more strongly associated with
intramuscular adipose tissue rather than fibrosis (Reimers et al.,
1993). Consequently, diagnostic ultrasound may be a practical
alternative approach to the assessment of both muscle mass and
muscle quality. While there is some evidence to support the
use of diagnostic ultrasound to estimate LBM (Sanada et al.,
2006; Pineau et al., 2007; Utter and Hager, 2008), this method
of body composition analysis is not widely used for sarcopenia
screening and staging. Currently, diagnostic ultrasound is not
identified as an accepted method to determine LBM by the
major international sarcopenia consensus groups (Cruz-Jentoft
et al., 2010; Lee et al., 2013; Dam et al., 2014). Therefore,
the objectives of this pilot study are to examine if a rapid
assessment method via mobile diagnostic ultrasound augments
well-known determinants of LBM to aid sarcopenia staging, and




Twenty community-dwelling women were enrolled for
participation in the study at the George Washington University
(GW) Exercise Physiology Lab in Washington, DC. The
Frontiers in Physiology | www.frontiersin.org 2 October 2015 | Volume 6 | Article 302
Ismail et al. Ultrasound muscle characteristics in women
study was approved by the GW Office of Human Research
Institutional Review Board, and registered with Clinicaltrials.gov
(NCT00303446). Signed informed consent was obtained
from all study participants prior to data collection. Inclusion
criteria for study enrolment included being an ambulatory
female adult between the ages of 18 and 75 years of age.
This sample of convenience was stratified to include an
equal number of people above and below the age of 55.
Federal agencies have identified the age range of 55–65
as a benchmark period to observe the emergence of age-
related health problems within U.S. populations (Schoenborn
and Heyman, 2009). Absolute contraindications included
pregnancy, medical conditions that result in edema, and
musculoskeletal or neurological disorders that are associated
with muscle atrophy. Relative contraindications were body
size dimensions that would preclude appropriate use of the
DXA scanner. Participant demographics are summarized in
Table 1.










Age (years) 43.4 ± 20.9 47.9 ± 21.3 39.0 ± 20.4 0.351
BMI† 23.8 (8.5) 28.8 (9.4) 21.5 (3.1) 0.001
aLM/ht2 (kg/m2) 6.96 ± 1.22 7.92 ± 0.88 6.00 ± 0.55 <0.001
Grip strength
(kgF /kgBW )
0.392 ± 0.089 0.345 ± 0.095 0.438 ± 0.054 0.017
Muscle thickness (cm)
Trapezius 1.20 ± 0.19 1.27 ± 0.20 1.12 ± 0.15 0.076
Brachioradialis 1.95 ± 0.35 2.06 ± 0.40 1.84 ± 0.27 0.170
Deltoid 2.29 ± 0.53 2.54 ± 0.48 2.04 ± 0.45 0.031
Pectoralis 0.78 ± 0.23 0.85 ± 0.28 0.70 ± 0.15 0.163
major
Rectus femoris 2.17 ± 0.54 2.34 ± 0.57 2.00 ± 0.48 0.157
Total muscle
thickness (cm)
8.39 ± 1.18 9.07 ± 1.12 7.70 ± 0.81 0.006
Echogenicity†‡ 47.50 (23.00) 58.50 (21.00) 38.00 (17.00) 0.003
Racial/ethnic group
Caucasian 9 (45.0%) 3 (30.0%) 6 (60.0%) –
African 4 (20.0%) 4 (40.0%) 0 (0.0%) –
American
Hispanic 2 (10.0%) 2 (20.0%) 0 (0.0%) –
Asian 5 (25.0%) 1 (10.0%) 4 (40.0%) –
HAQ 0.45 ± 1.10 0.50 ± 0.97 0.40 ± 1.27 0.605
Audit-C† 2.0 (2.0) 2.0 (2.0) 2.0 (2.0) 0.586
LBM, lean body mass; sig, significant; BMI, body mass index; aLM/ht2, appendicular
lean mass scaled to height; F, force; BW, body weight; HAQ, The Health Assessment
Questionnaire; Audit-C, The Alcohol Use Disorders Identification Test.
Data expressed as means (± standard deviation); statistically significant differences
between the Normal LBM subgroup and the Low LBM subgroup were determined using
the independent t-test (p < 0.05).
†Data expressed as medians (interquartile range); statistically significant differences
between the Normal LBM subgroup and the Low LBM subgroup were determined using
the Mann Whitney U-test (p < 0.05).
‡Echogenicity is expressed via grayscale values (0–255).
Procedures
The primary estimate of LBM was obtained via whole body DXA
imaging using a GE Lunar iDXA machine (GE Medical Systems
Ultrasound & Primary Care Diagnostics, LLC, Madison, WI,
USA). A single trained DXA technician administered all DXA
examinations using the GE Encore v15 SP2 software package for
the LBM data acquisition and analysis. The body composition
data collected during the DXA examinations included estimates
of absolute and percentage of total LBM, aLM/ht2, and body fat
percentage (BF%). The aLM values were calculated as the sum
of LBM in the arms and legs and scaled to height (aLM/ht2).
Participant preparation and positioning for DXA was according
to the GE DXA machine manufacturer’s manual and the GW
Exercise Science Laboratory testing procedures. DXA scans
were obtained on the same day as the diagnostic ultrasound
examination. Similar DXA imaging equipment and examination
procedures (Hull et al., 2009) have yielded reliable measurement
results (ICC = 0.97, p < 0.0001; CV = 5.5% for LBM) (Aasen
et al., 2006).
Sonographic estimates of LBM (aggregate muscle thickness,
cm) and myosteatosis (echogenicity levels expressed as grayscale
values, 0–255) were obtained by a single trained and certified
sonographer. Image capture was completed using a portable,
diagnostic ultrasound device (SonoSite M-Turbo 1.1.2; SonoSite,
Inc., Bothell, WA, USA) with a 13.6 MHz linear array transducer
and B-mode scanning. Ample amounts of water-soluble
transmission gel was applied to the transducer in order to
maintain adequate acoustic contact with the skin surface.
Minimal examiner pressure was exerted during the scanning
to attain sufficient image resolution while incurring nominal
tissue deformation. The unilateral (Abe et al., 1994) axial and
appendicular sites included the midpoint of the upper trapezius,
upper pectoralis major, lateral deltoid, proximal forearm (mobile
wad compartment), and rectus femoris (dominant side only)
as identified via palpation of surface anatomy and confirmed
via real-time sonography. Imaging was completed while the
participants were seated with their feet on the floor and upper
arms relaxed and aligned with the trunk. Their elbows, hips, and
knees were positioned with approximately 90◦ of flexion. These
anterior locations were determined by considering accessibility
during their future use with non-ambulatory patients, the
targeted region of interest (ROI) relative to the ultrasound
imaging window and depth, previous use in other investigations,
or clear anatomical landmarks that aid the imaging process
(Bemben, 2002; Ismail et al., 2014). All longitudinal view images
were obtained and measured 3 times using digital calipers within
the fascial boarders of the muscle at the time of image capture,
and the values were averaged prior to analysis. Acceptable
intra-rater reliability (Bemben, 2002; O’Sullivan et al., 2007)
for diagnostic ultrasound assessment has been found for tests
involving the thickness and cross-sectional area of the rectus
femoris [ICC(3,2) = 0.72–0.99, p < 0.05; CV = 3.5–6.7%]
and similar morphology measures for the trapezius have also
been reported as reliable [ICC(3,3) = 0.88–0.96, p < 0.05].
Also, the investigators involved in this study demonstrated a
CV of 1.6–2.9% for material thickness measures across 6 raters
using a calibration phantom (Harris-Love et al., 2014b) and high
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interrater reliability [ICC(2,k) = 0.992–0.996, p < 0.001] for
the assessment of echogenicity at the rectus femoris via grayscale
histogram analysis (Harris-Love et al., 2015b).
Additional assessments included hand grip dynamometry
(Jamar, Lafayette Instruments, Lafayette, IN) using the mean
value of 3 trials under standardized conditions (Günther et al.,
2008). Grip strength is a frequently used impairment measure
in studies concerning general muscle function and older adults
(Vermeulen et al., 2015), and the reliability of the Jamar
dynamometer is suitable for clinical research settings (ICCs =
0.97–0.98, p < 0.01). Basic anthropometric measures such as
height (cm) with a stadiometer and body mass (kg) with a
balance scale were completed prior to body composition testing,
and participants provided general information concerning
racial/ethnic group identify, limb dominance (based on the stated
preference for handwriting and kicking a ball), past medical
history, alcohol intake (The Alcohol Use Disorders Identification
Test, AUDIT-C) (Bradley et al., 2007), health-related quality of
life (The Health Assessment Questionnaire, HAQ) (Bruce and
Fries, 2003), and smoking behavior.
Data Analysis
Descriptive statistics are used to depict participant characteristics
and the outcome measures, and data are expressed as means
and standard deviations. The major outcomes in this study
have normal data and variance distributions based on the
Shapiro-Wilk and Levene’s test, respectively, except for the
ultrasound echogenicity grayscale values and BMI. These data are
shown as median values with the interquartile range (IQR) and
further analyses are completed using non-parametric statistics
or log10(x) data transformations (Portney and Watkins, 2009).
Inferential statistics include an analysis of relationships among
the measures of body composition and muscle performance.
Pearson product-moment correlation coefficients (PMCC, r),
partial correlations (rxyz), and Spearman’s correlation coefficients
(Spearman’s rho, ρ) are used to assess the association between
variables, and the strength of the association among the variables
is based on Munro’s criteria (Munro, 2001). Independent t-tests
and Mann Whitney U-tests are used to determine the difference
among the variables based on the categorization of participants in
“Normal LBM” and “Low LBM” subgroups. The LBM criterion
is based on the Class I designation for sarcopenia in women
(5.76–6.75 kg/m2) by Janssen and colleagues (Janssen et al., 2004).
Nested linear multiple regression with a priori variable
selection is used to assess the presumed association of LBM
with measures of body size, ultrasound morphometry measures
of muscle thickness, and age. Significant improvements in the
regression models are based of the change in F-values derived
from an analysis of variance (ANOVA). Stepwise multiple linear
regression analysis is used to determine the association of muscle
strength with LBM, echogenicity, body size, body fat (BF),
and age. Data residuals are assessed for homoscedasticity and
Cook’s Distance scores are assessed to ensure that individual data
are not disproportionately influencing the regression equation.
Multicollinearity of the covariates is initially assessed through the
review of a correlation matrix, and then calculating the variance
inflation factors (VIF), tolerance statistics (1/VIF), and the
covariate dependency associated with each eigenvalue following
the regression analysis (Field, 2009). VIF values =10 denote
multicollinearity, and an average VIF> 1 or 1/VIF< 0.1 prompts
the review of the variance proportions associated with the
eigenvalue dimensions for the final regression model. Covariate
dependency observed within any eigenvalue dimension will also
serve to confirm the presence of multicollinearity.
The construct of “strength” is represented by the averaged
peak grip force values scaled to body weight given the well-
known influence of body size on the expression on unadjusted
strength values (kg of peak force/kg of body weight) (Jaric, 2002,
2003). Echogenicity measures are expressed as median grayscale
values (a unitless 0–255 scale, with higher values indicating
more hyperechoic material) via image analysis using Adobe
Photoshop R© version 6 (Adobe Systems, Mountain View, CA,
USA) (Harris-Love et al., 2015b). Total sample data and/or
subgroup data were subject to analysis based on the nature of
a given research question associated with the study objectives.
Statistical analyses were performed using SPSS statistical software
version 10.0 for Windows (SPSS Inc., Chicago, IL, USA). The α
level was set at 0.05, and two-tailed p < 0.05 were considered
significant for all inferential statistics.
RESULTS
Participant Characteristics
Our sample includes 20 female participants with a mean age of
43.4 ± 20.9 years with a median BMI of 23.8 (IQR, 8.5) and a
mean aLM/ht2 of 6.96± 1.22. Ratings of health-related quality of
life via the HAQ were similar to those reported in population-
based studies, no excessive alcohol intake was detected using
the Audit-C questionnaire, and no participant reported a history
of smoking (Bruce and Fries, 2003; Bradley et al., 2007). The
assignment of participants to Normal LBM and Low LBM
subgroups reveals that the Normal LBM subgroup exhibit higher
BMI values (p = 0.001) and echogenicity levels (p = 0.003), but
lower scaled grip strength values (p = 0.017) in comparison to
the Low LBM group. Ultrasound estimates of LBM via aggregate
total muscle thickness values significantly discriminate between
the Normal LBM and the Low LBM subgroups (p = 0.006).
All participant characteristics and demographic information are
provided in Table 1.
Using Ultrasound Muscle Characteristics
to Improve Predictors of Lean Body Mass
While ultrasound morphometry measures are independently
associated with LBM (r = 0.64, p = 0.002), a multiple regression
model using the aggregate ultrasound muscle thickness measures
with estimates of body size and participant age provides the
strongest association with DXA LBM values. The iterations of
the linear regression model show that BMI alone is a predictor
of aLM/ht2 [adjusted R2 of 0.61, p < 0.001, using log10 (x) values
for BMI]. However, the model is significantly improved [1 R2 =
0.13, F(2,17) = 32.5, p < 0.004] with the addition of aggregate
ultrasound muscle thickness (adjusted R2 of 0.77, p < 0.001)
and age [1R2 = 0.08, F(3, 16) = 35.4, p < 0.007] as predictor
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variables. The a priori regression model of BMI, ultrasound
muscle thickness, and age yields an adjusted R2 of.85 (p < 0.001;
Table 2). The partial correlations within this model show the
strength of association between BMI and aLM/ht2 (rxyz = 0.88).
Contributing predictor variables, ultrasound muscle thickness
and age, exhibit a similar magnitude of association with aLM/ht2
(rxyz = 0.58 and −0.61, respectively). In examining the potential
presence of multicollinearity within the regression model, the
1/VIF was 0.66–0.76 and the VIF was 1.3–1.5. The variance
proportions associated with the eigenvalue dimensions do not
reveal covariate dependency. The highest regression coefficient
variances observed across all eigenvalue dimensions are for BMI
(0.97) and age (0.16) within eigenvalue dimension 4 of the final
regression model.
Muscle Quality Estimates, Body
Composition Estimates, and Peak Force
Generation
Estimates of muscle quality, proportion of total body fat, and
age, but not LBM, are significantly associated with scaled peak
force production. Peak force generation was represented by
dominant limb grip dynamometry scaled to body weight in
our sample (differences between dominant and non-dominant
strength values were not significant; data not shown). Participant
age and ultrasound echogenicity measured at the dominant
limb rectus femoris are moderately associated with strength
(r = −0.69, p = 0.001, and ρ = −0.67, p = 0.001, respectively).
Considering the body composition measures obtained using
DXA, percentage body fat (BF%) is moderately associated
with scaled peak force (r = −0.63, p = 0.003), but
LBM as estimated with aLM/ht2 is not (r = −0.34, p =
0.14).
The bivariate linear regression model with age as a predictor
of scaled peak force yields an adjusted R2 of 0.39, p = 0.002.
The addition of ultrasound echogenicity, as quantified with
grayscale histogram analysis [using log10 (x) grayscale values],
significantly improves the model [1 R2 = 0.16, F(2,18) =
11.8, p = 0.017]. The multiple regression model with age and
echogenicity as predictor variables accounts for approximately
53% of the variance in the scaled peak force values (p = 0.001;
TABLE 2 | Regression model for aLM/ht2.
Model r R2 Adjusted R2 Std. Error of
the Estimate
F Sig.
1 0.81 0.66 0.61 0.731 35.1 <0.001
2 0.89 0.79 0.77 0.588 32.5 <0.001
3 0.93 0.87 0.85 0.482 35.4 <0.001
The linear regression model features lean body mass obtained from dual energy X-ray
absorptiometry (DXA) as the dependent variable and the body mass index (BMI) with the
aggregate muscle thickness value (US) and age as predictor variables.
This a priori model utilized a nested linear, multiple regression model with forward
entry—Predictors: (1) log10 (BMI); (2) log10 (BMI) + aggregate muscle thickness (via
ultrasound, cm); (3) log10 (BMI) + aggregate muscle thickness (via ultrasound, cm) +
age (years). Dependent Variable: DXA lean body mass (aLM/ht2 ). Model 3: Y= −9.078+
10.210(log10 (BMI)) + 0.302(US) + −0.019(age).
Table 3). The partial correlations within this model suggest that
echogenicity may have a greater magnitude of association with
scaled peak force (rxyz = −0.52) in comparison with participant
age (rxyz = −0.38). The addition of other predictor variables
associated with body size and body composition, such as BMI
and BF%, only serve to diminish the integrity of regression
model (F-value decreases from 13.3 to <7.9 without a resultant
increase in the adjusted R2-value). Regression model diagnostics
are negative for multicollinearity based on a 1/VIF of 0.62, a
VIF of 1.6, and an absence of covariate dependency within
the eigenvalue dimensions. Figure 1 depicts the scatterplot for
scaled peak force and echogenicity expressed as grayscale values
(log10(x)).
DISCUSSION
Age-related muscle dysfunction may be marked by both a
loss of LBM and diminished muscle tissue composition. While
the assessment of muscle quality is not yet included in the
staging algorithm for sarcopenia (Lee et al., 2013), intrinsic
TABLE 3 | Regression model for grip strength.
Model r R2 Adjusted R2 Std. Error of
the Estimate
F Sig.
1 0.65 0.42 0.39 0.068 13.26 0.002
2 0.76 0.58 0.53 0.059 11.75 0.001
The linear regressionmodel features peak force obtained via grip dynamometry and scaled
to body weight as the dependent variable and subject age and ultrasound echogenicity
as estimated via grayscale analysis as the predictor variables.
This model utilized a nested linear multiple regression with forward variable entry—
Predictors: (1) age; (2) age + log10 (echogenicity via grayscale). Dependent Variable:
grip strength (scaled to body weight; dominant side). Model 2: Y = 0.969−0.306(log10
(echogenicity using grayscale values)) −0.001(age).
FIGURE 1 | Bivariate relationship between grip strength and muscle
echogenicity. The scatterplot depicts the inverse relationship between grip
strength (peak force scaled to body weight) and muscle quality as measured
via grayscale histogram analysis of the rectus femoris echogenicity.
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muscle characteristics beyond size are known to affect strength
and contribute to mobility limitations (Goodpaster et al., 2001;
Ferrucci et al., 2011). Mobile, diagnostic ultrasound has been
proposed as a method to obtain estimates of muscle mass and
muscle quality, while circumventing the constraints of traditional
imaging modalities related to access, cost, and radiation exposure
(Pillen and van Alfen, 2011; Harris-Love et al., 2014c). The
primary objectives of this study are to examine if diagnostic
ultrasound muscle characteristics help to improve well-known
determinants of LBM, and if the measurement of muscle
quality via ultrasound echogenicity is associated with muscle
performance.
Diagnostic Ultrasound and LBM Estimates:
Improving on Available Clinical Information
Standard clinical information such as age and BMI are
significantly associated with LBM, but fall short of full
consideration as proxy measures. Our data is consistent with
the findings of a larger study conducted by Iannuzzi-Sucich
and colleagues (Iannuzzi-Sucich et al., 2002) who determined
that BMI independently accounts for approximately 50% of the
variance in aLM/ht2. Also, Goodman and associates (Goodman
et al., 2013) have used logistic regression models with factors
for BMI and age to identify older men and women with
low aLM/ht2 based on data culled from the National Health
and Nutrition Examination Surveys database (1999–2004) and
comparisons with a young cohort reference group. In this study,
we have used a conceptual aLM/ht2 prediction model based
on BMI, age, and a direct measure of muscle morphometry
via diagnostic ultrasound. The general use of BMI remains
problematic (Romero-Corral et al., 2008; Harris-Love et al.,
2014a) concerning the misclassification of very fit individuals
as “overweight,” its potential overestimate of obesity rates in
African Americans, and the wide range of BF% levels attributed
to people with a BMI range between 20 and 30. However, the
value of retaining BMI within the proposed aLM/ht2 prediction
model is its significant association with LBM in many patient
populations, and its representation of body size which serves
to provide a scaling factor for the aggregate muscle thickness
values obtained via sonography. An additional potential benefit
of using diagnostic ultrasound data for an aLM/ht2 prediction
model, and during the general sarcopenia assessment process,
is the viable opportunity to integrate estimates muscle quality
into the sarcopenia staging algorithm. The development of
valid predictive models of LBM still remains an important goal
concerning the staging of sarcopenia and the monitoring of other
chronic conditions. Indeed, low LBM and muscle performance
constitute health concerns that may act as independent mortality
risk factors (Alexandre et al., 2014). Nevertheless, muscle quality
may surpass muscle mass as a contributor to age-related
decreases in muscle strength and power, and negatively impact
functional independence (Fukumoto et al., 2012; Watanabe et al.,
2013; Rech et al., 2014). Additional investigation will be needed
to refine the operational definitions of muscle quality and to
understand how to best incorporate this muscle characteristic
into the sarcopenia syndrome framework.
Muscle Quality Should Not Be Ignored as a
Component of the Sarcopenia Syndrome
Older adults categorized as mildly overweight based on their
BMI are less likely to develop sarcopenia using LBM as the
criterion (Yu et al., 2014). Individuals that are mildly overweight
may exhibit a protective effect against muscle loss and maintain
functional independence as they age despite a concomitant
increased risk for cardiovascular disease and other systemic
disorders (Cetin and Nasr, 2014). Indeed, BMI significantly
(p = 0.001) discriminates between participants in this study
assigned to the Normal LBM subgroup (>6.75 kg/m2) and Low
LBM subgroup (5.76–6.75 kg/m2). The Normal LBM subgroup
has a mean LBM value of 7.92 ± 0.88 kg/m2 and a BMI of
28.8 (IQR, 9.4), whereas the Low LBM subgroup has a mean
LBM value of 6.00 ± 0.55 kg/m2 and a BMI of 21.5 (IQR,
3.1). Therefore, the Normal LBM subgroup appears to reflect
previously published findings concerning the LBM sparing effect
of higher relative body weight levels. Nevertheless, the Normal
LBM subgroup also exhibits lower scaled peak force values
and higher echogenicity values in comparison to the Low LBM
subgroup (Figure 2). The women assigned to the Low LBM
FIGURE 2 | Diagnostic ultrasound image of the rectus femoris region
of interest and the corresponding grayscale histogram analysis values.
The exemplar images depict the diagnostic ultrasound transverse muscle
images on the left and the grayscale histograms on the right. The bottom
ultrasound image shows greater hyperechoic properties in comparison to the
top image. The comparatively hyperechoic image characteristics of the bottom
image correspond to grayscale histogram data with a wider distribution and a
shift to the right which is associated with larger grayscale values. The
grayscale value of the bottom image is 66.9 and may indicate a greater
proportion of intramuscular adipose tissue in comparison to the top image
(grayscale value, 35.6).
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subgroup are classified as having “healthy body weight” per
the BMI designation, and they also have a lower proportion
of total body fat, higher relative strength levels based on grip
dynamometry, and better estimates of muscle quality (i.e., 35%
lower echogenicity levels in comparison to the Normal LBM
subgroup; Table 1).
While forms of muscle quality are not part of the current
sarcopenia staging algorithm, the concept remains useful for
examining contributing factors to muscle performance. Muscle
quality in sarcopenia studies is sometimes expressed as peak force
generated from a single testing maneuver scaled to regional DXA
estimates of muscle mass (Cawthon et al., 2009; Hairi et al.,
2010). Scaling net muscle force production relative to muscle
mass or body mass allows one to compare strength within a
heterogeneous sample regarding body stature, and account for
the effect of body size on strength-function relationships (Jaric,
2003). Recently, the investigators involved in the Foundation
for the National Institutes of Health (FNIH) Sarcopenia Project
examined grip strength cut points related to mobility limitations.
Although they opted to affirm the use of absolute strength
values in a manner similar to other international sarcopenia
consensus groups (Lee et al., 2013), they did note the modest
improvements in the model equations for women within their
pooled cross-sectional sample when using grip strength scaled
to BMI (Alley et al., 2014). While, the aforementioned scaling
approach has been termed “specific force” in previous studies
(Cawthon et al., 2009; Hairi et al., 2010), there may be important
distinctions between scaling factors and specific force that merit
consideration. Specific force has traditionally been determined
by calculating muscle strength relative to whole muscle cross-
sectional area (CSA), and is usually depicted as a simple linear
relationship that may have some validity in unipennate muscles
with fairly uniform architecture. However, the assumptions of
specific force derived from CSA estimates do not apply to the
vast majority of muscle groups. Consequently, specific force
is often formally expressed as the quotient of muscle force
and physiologic cross-sectional area (PCSA), which incorporates
aspects of muscle architecture such as muscle fiber length and
pennation angle (Blemker et al., 2005; Morse et al., 2008;
Krivickas et al., 2011). Additional intrinsic factors such as
moment arm length, muscle fiber type, muscle action mode,
bioenergetics, excitation-contraction coupling, and muscle tissue
composition act to influence specific force. Furthermore, factors
extrinsic to the muscle—but inextricably linked with net force
production—include sufficient cortical excitability, the integrity
of pyramidal neurons, the synchrony and rate coding of alpha
motor neurons, and the impact of age-related motor neuron loss
(Manini et al., 2013; Lieber, 2010). Given the varied physiological
factors that govern muscle performance, these insights imply that
the use of specific force to represent muscle quality has important
constraints. Rather, the calculation of specific force could be
considered as one of many impairment-level outcomes that are
responsive to changes in muscle quality and other facets of the
neuromuscular milieu.
In this report, muscle quality is operationally defined as
muscle tissue echogenicity which serves as a proxy measure
for tissue composition (Reimers et al., 1993; Sipilä and
Suominen, 1993). The rationale for considering diminished
tissue composition as a major indicator of age-related muscle
changes is partially validated through the significant inverse
relationship between scaled peak force and echogenicity observed
in our data (Figure 1). Given that LBM did not have a
meaningful association with scaled peak force, and that age and
echogenicity accounted for approximately 50% of the variance
in strength levels, our pilot data allows for the consideration of
additional intrinsic and extrinsic muscle factors contributing to
the observed strength levels within the sample.
Study Implications and Limitations
The findings from this study suggest that diagnostic ultrasound
may be used in combination with readily available clinical
information to estimate LBM. Although the models derived from
the data must be considered exploratory given the limited sample
size, the a priori explanatory variables lend strength to our
general approach (Field, 2009). While the coefficients used in the
regression equations may change substantially during validation
with a larger sample and with the inclusion of male subjects, we
hypothesize that the explanatory variables of BMI, ultrasound
muscle thickness, and age will retain their value within the
model. Use of the Class I designation for sarcopenia in women
(i.e., 5.76–6.75 kg/m2) is appropriate for our participants given
their relatively high level of physical functioning, and serves
as an approach to discriminate meaningful body composition
differences within the sample (Janssen et al., 2004). More
stringent LBM criterion values, such as those ascribed to the
Class II sarcopenia designation or the FNIH sarcopenia staging
algorithm, yield lower prevalence values (Clynes et al., 2015)
and may be more suitable for population-based studies with a
sufficient representation of participants with a high degree of
physical impairment.
Muscle echogenicity was significantly associated with peak
muscle force in our sample. It is important to note that the
sonographic morphology measures used for the proxy muscle
tissue composition estimates were obtained at the rectus femoris.
The selection of the rectus femoris for echogenicity assessment
is influenced by its favorable architecture and uniform geometry
in the longitudinal orientation during scanning. Previous
observations confirm that echogenicity of skeletal muscles vary
with their location within the body, with muscle groups within
the lower compartment of the leg having higher echogenicity
in comparison to selected upper body muscle groups (Scholten
et al., 2003; Pillen and van Alfen, 2011). We hypothesized that
while skeletal muscles have differing levels of echogenicity based
on their location and metabolic profile, age-related changes
in muscle tissue composition would be systemic and result in
a broad increase in echogenicity across muscle groups. This
proposed phenomenon is partially supported by our findings
in this study concerning the observed significant relationship
between echogenicity at the rectus femoris with peak grip force.
Just as grip strength has been used as a global measure that
may be significantly associated with knee extension strength and
general physical performance in older adults (Aadahl et al., 2011;
Cooper et al., 2013), echogenicity at the knee extensors may be
a general indicator of muscle quality that is inversely related
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with grip strength and general measures of muscle performance.
For example, our preliminary data (Harris-Love et al., 2015a)
involving a group of older men suggest that echogenicity levels
at the rectus femoris are significantly related to scaled peak grip
strength, walking speed, and the timed sit-to-stand test (r =
−0.30 to −0.71, p < 0.05). Further study will be needed to
better understand the effect of sexual dimorphism on the age-
related changes in muscle tissue composition as assessed with
sonographic proxy measures. Also, larger follow up studies will
be needed to explore the risk of incident mobility limitations and
physical disability based on muscle quality estimates as described
in this work.
Investigators have also reported findings that suggest that
changes in muscle tissue composition may differentially affect
people of African descent (Song et al., 2004; Miljkovic-Gacic
et al., 2008; Miljkovic et al., 2009). Both advancing age and
BF% may be associated with adverse changes in muscle tissue
composition. However, high levels of intramuscular adipose
tissue in African Americans may be observed in those classified
as having “healthy body weight” based on their BMI, and be
independent of central adiposity (Miljkovic-Gacic et al., 2008).
Individuals with this type of muscle tissue composition profile
may have associated health problems that include metabolic
dysfunction or diminished muscle performance, and yet not
meet the staging criteria for sarcopenia. Indeed, there is
some evidence to suggest that African Americans may have a
lower prevalence of sarcopenia in comparison to non-Hispanic
Whites (Castaneda and Janssen, 2005). We do not have a
sufficient sample size to subject our racial/ethnic group data
to inferential analysis. However, we observed that none of our
African American or Hispanic participants are in the Low LBM
subgroup (Table 1). These 6 participants are in the Normal
LBM subgroup which is characterized by higher mean BMI and
median echogenicity values in comparison to the Low LBM
subgroup. Other limitations in this work related to the modest
sample size include the departures from normality related to
the distribution of the BMI and grayscale values which was
addressed via data transformation. Also, the constraints of
standard diagnostic ultrasound imaging did not allow for us to
obtain the additional measures of CSA or PSCA at the mid-
thigh. While grip dynamometry is the recommended means of
strength testing according to the leading sarcopenia consensus
organizations (Cruz-Jentoft et al., 2010; Cruz-Jentoft andMorley,
2012; Dam et al., 2014), the study findings may have been
enhanced by obtaining estimates of lower extremity muscle
performance.
It remains to be seen if screening for age-related changes in
muscle quality may be effectively used to modify the risk of
developing chronic disease and disabling conditions related to
musculoskeletal health. In addition, the benefits of diagnostic
ultrasound to characterize skeletal muscle have to be considered
with the shortcomings of the imaging modality related to
equipment access, examiner training, limited normative datasets,
and the inter-machine equivalence of echogenicity values
(Harris-Love et al., 2014c).
CONCLUSIONS
Diagnostic ultrasound may provide a clinically viable means to
assess both muscle mass and muscle quality. Our study findings
indicate that a conceptual aLM/ht2 prediction model based on
BMI, age, and a direct measure of muscle morphometry via
diagnostic ultrasound, accounts for 85% of the variance in DXA
LBM values for our sample. Moreover, our data suggest that
age and muscle echogenicity, are significantly associated with
scaled peak force production in the women that participated in
our study. In contrast, DXA LBM is not significantly associated
with scaled peak force generation in our participants. The higher
total BF% of the Normal LBM subgroup may have conferred a
protective effect against low muscle mass, but not myosteatosis.
The women in the Normal LBM subgroup exhibit higher BMI
values and echogenicity levels, but lower scaled peak force values
in comparison to the Low LBM group. Follow up studies should
include validation of the aLM/ht2 prediction model, and the
integration of ultrasound estimates of muscle quality into the
sarcopenia staging algorithm.
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